Key Takeaways
- Boule Diagnostics is a diagnostic company based in Sweden that develops, manufactures and sells systems and consumables for haematology.
- The company primarily targets small and mid-size hospitals, clinics and laboratories in non-institutional healthcare.
- Boule’s operations are conducted through commercial subsidiaries in Sweden, the US and China.
- The company’s history dates back to the 1950s with the development of Europe’s first automatic blood cell counter.
With an innovative legacy that dates back to the 1950s, Swedish-based company, Boule Diagnostics, is revolutionising non-institutional healthcare with diagnostic products that are being used worldwide. The company, a pioneer in haematology diagnostics, has a track record of developing automatic blood cell counters which have been instrumental in the evolution of haematological diagnostics. Boule Diagnostics has leveraged on their decades of expertise to provide solutions primarily for small to mid-size hospitals, clinics, laboratories, and other diagnostic companies both in human and veterinary haematology.
Engaging with more than 100 countries through a network of distributors, Boule Diagnostics has established footholds not only in Sweden but also in the United States and China. Their extensive reach signifies the global relevance and impact of the innovative solutions they offer, demonstrating how a Swedish company can foster a far-reaching impact on the international stage in the realm of non-institutional haematology diagnostics.
What makes Boule Diagnostics stand out in the health diagnostics sector is its unwavering commitment to innovation. The firm sees the future of diagnostics, not simply in making incremental improvements, but in driving revolutionary changes. It traces its roots back to the time when founder Erik Öhlin developed Europe’s first automatic blood cell counter. Boule’s American subsidiary, Clinical Diagnostic Solutions Inc., boasts a similar history and was developed by the people from Coulter Corporation, which made the world’s first blood cell counter.
In addition to its expansive product line, Boule Diagnostics has implemented an effective business model that prioritizes relationships with distributors and hospitals worldwide. By doing so, they can provide customized solutions tailored to different regional specificities and institutions, a factor which sets them apart within the non-institutional haematology diagnostics sector.
Moving towards the future, Boule Diagnostics aims to continue its mission of revolutionising haematology diagnostics globally. Its Swedish beginnings only underscore its potential to foster more medical breakthroughs and to cement its place as an influential player in the global health diagnostics industry. As they are expanding their product range and enhancing their manufacturing processes, Boule Diagnostics is geared towards driving more innovations and leading the charge for better medical diagnostics.
The possibilities are limitless for Boule Diagnostics. With continued dedication to develop innovative and accessible diagnostic solutions, Boule is indeed an exemplifier of how Swedish innovation is revolutionising global non-institutional haematology diagnostics. To keep up with their journey, you can follow them on their LinkedIn.
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!
